rs62636645

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003850.3(SUCLA2):ā€‹c.110T>Gā€‹(p.Leu37Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00414 in 1,614,086 control chromosomes in the GnomAD database, including 218 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.022 ( 129 hom., cov: 32)
Exomes š‘“: 0.0023 ( 89 hom. )

Consequence

SUCLA2
NM_003850.3 missense

Scores

1
3
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 6.88
Variant links:
Genes affected
SUCLA2 (HGNC:11448): (succinate-CoA ligase ADP-forming subunit beta) Succinyl-CoA synthetase (SCS) is a mitochondrial matrix enzyme that acts as a heterodimer, being composed of an invariant alpha subunit and a substrate-specific beta subunit. The protein encoded by this gene is an ATP-specific SCS beta subunit that dimerizes with the SCS alpha subunit to form SCS-A, an essential component of the tricarboxylic acid cycle. SCS-A hydrolyzes ATP to convert succinate to succinyl-CoA. Defects in this gene are a cause of myopathic mitochondrial DNA depletion syndrome. A pseudogene of this gene has been found on chromosome 6. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0027971268).
BP6
Variant 13-47997004-A-C is Benign according to our data. Variant chr13-47997004-A-C is described in ClinVar as [Benign]. Clinvar id is 139363.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0744 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SUCLA2NM_003850.3 linkuse as main transcriptc.110T>G p.Leu37Trp missense_variant 2/11 ENST00000646932.1 NP_003841.1 Q9P2R7-1E5KS60Q9Y4T0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SUCLA2ENST00000646932.1 linkuse as main transcriptc.110T>G p.Leu37Trp missense_variant 2/11 NM_003850.3 ENSP00000494360.1 Q9P2R7-1

Frequencies

GnomAD3 genomes
AF:
0.0219
AC:
3338
AN:
152162
Hom.:
126
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0764
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00805
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000220
Gnomad OTH
AF:
0.0138
GnomAD3 exomes
AF:
0.00569
AC:
1430
AN:
251236
Hom.:
45
AF XY:
0.00397
AC XY:
539
AN XY:
135806
show subpopulations
Gnomad AFR exome
AF:
0.0750
Gnomad AMR exome
AF:
0.00390
Gnomad ASJ exome
AF:
0.00198
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000196
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000299
Gnomad OTH exome
AF:
0.00342
GnomAD4 exome
AF:
0.00228
AC:
3327
AN:
1461806
Hom.:
89
Cov.:
31
AF XY:
0.00204
AC XY:
1486
AN XY:
727208
show subpopulations
Gnomad4 AFR exome
AF:
0.0757
Gnomad4 AMR exome
AF:
0.00400
Gnomad4 ASJ exome
AF:
0.00195
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000197
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000174
Gnomad4 OTH exome
AF:
0.00507
GnomAD4 genome
AF:
0.0221
AC:
3358
AN:
152280
Hom.:
129
Cov.:
32
AF XY:
0.0214
AC XY:
1595
AN XY:
74474
show subpopulations
Gnomad4 AFR
AF:
0.0766
Gnomad4 AMR
AF:
0.00804
Gnomad4 ASJ
AF:
0.00202
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000221
Gnomad4 OTH
AF:
0.0137
Alfa
AF:
0.00409
Hom.:
26
Bravo
AF:
0.0253
ESP6500AA
AF:
0.0760
AC:
335
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00673
AC:
817
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000652

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicSep 18, 2017- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsNov 20, 2017- -
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsNov 23, 2015- -
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxOct 17, 2011This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
23
DANN
Benign
0.91
DEOGEN2
Benign
0.24
T;T;.;.;.;T
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.61
.;T;T;T;T;T
MetaRNN
Benign
0.0028
T;T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.69
N;N;.;.;.;.
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-0.96
.;N;.;.;.;.
REVEL
Benign
0.16
Sift
Benign
0.16
.;T;.;.;.;.
Sift4G
Benign
0.12
.;T;.;.;.;T
Polyphen
0.95
P;P;.;.;.;.
Vest4
0.61, 0.52
MVP
0.81
MPC
0.81
ClinPred
0.019
T
GERP RS
5.7
Varity_R
0.085
gMVP
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs62636645; hg19: chr13-48571139; API